Revelation Biosciences, Inc. (REVB)

Revelation Biosciences Stock Forecast

Stock Price Forecast

There have not been any analyst price target forecasts for Revelation Biosciences in the last 12 months.

Price Target: n/a

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for Revelation Biosciences.

Recommendation Trends

Rating	Dec '22	Jan '23	Feb '23
Strong Buy	1	1	0
Buy	0	0	0
Hold	0	0	0
Sell	0	0	0
Strong Sell	0	0	0
Total	1	1	0

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jonathan Aschoff Roth MKM	Roth MKM	Strong Buy Maintains $28,800 → $86,400	Strong Buy	Maintains	$28,800 → $86,400	+7,081,867.21%	Feb 14, 2023
Jonathan Aschoff Roth Capital	Roth Capital	Strong Buy Initiates $2,419,200	Strong Buy	Initiates	$2,419,200	+198,294,981.97%	Feb 17, 2022

Financial Forecast

• Revenue This Year:
  n/a
• Revenue Next Year:
  n/a
• EPS This Year:
  -4.24

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	-	-	-	-	-
Revenue Growth	-	-	-	-	-	-	-
EPS	-	-	-	-1,052.16	-23.95	-4.24	-3.42
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	4	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027	2028	2029	2030
High	-2.75	-2.47
Avg	-4.24	-3.42
Low	-5.58	-4.26

EPS Growth

EPS Growth	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.